Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?
Impact of obesity in the setting of high-dose chemotherapy
Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)
Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen
Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing
Outcome of 67 patients with solid tumors relapsed after high-dose chemotherapy and peripheral blood stem cell transplantation
The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation
Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma
High rates of infection and colonization by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation
Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation
IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs
Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study
A rat model of syngeneic bone marrow transplantation during breast cancer therapy
A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia
Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation
Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning
Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT
Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT
Mean fluorescence intensity (MFI) of beta2 integrin (CD11a and CD11b) expression on peripheral blood (PB) CD34-positive (CD34+) cells in steady state correlates inversely with the total amount of harvested CD34+ cells
Late-onset Epstein-Barr virus (EBV)-negative extranodal B-precursor lymphoblastic lymphoma of donor origin after hematopoietic stem cell transplantation (HSCT)